|
Post by mango on Apr 16, 2020 7:05:35 GMT -5
New Corporate Website. I really like it. It has such a better flow and is more appealing. I love the tributes to Al Mann on the website. I really like the History Timeline you can swipe through. That is neat. Pipeline page looks so much better. I like the colorway. Overall nicely done and a major improvement. I had to clear by browser cache to see the new website, FYI.
|
|
|
Post by mango on Apr 16, 2020 8:20:20 GMT -5
The Second Molecule
|
|
|
Post by mango on Apr 16, 2020 8:28:48 GMT -5
I wonder if ALB will still be speaking next month at the Cannabinoid Conference in Europe about the Phase 0 trial results with Technosphere Cannabinoids... • What is Phase 0? —Phase 0 trials are also known as human microdosing studies and are designed to speed up the development of promising drugs or imaging agents by establishing very early on whether the drug or agent behaves in human subjects as was expected from preclinical studies. en.m.wikipedia.org/wiki/Phases_of_clinical_research#Phase_0
|
|
|
Post by Clement on Apr 16, 2020 8:32:03 GMT -5
Tadalafil is the second (previously undisclosed) molecule! Thanks, Mango.
|
|
|
Post by Clement on Apr 16, 2020 8:53:31 GMT -5
Also on the new pipeline page, we find the following info about Epinephrine Technosphere: "Currently on hold pending interest from potential collaborators. Diligence package includes preclinical studies and minutes of a pre-IND meeting with the FDA."
|
|
|
Post by mango on Apr 16, 2020 9:08:18 GMT -5
Tobramycin Technosphere formulation is also scheduled for this year.
Even though the COVID-19 drugs with Immix are supposed to be classified, Mike slipped up in yesterday's call and named one of them.
The audio was fuzzy but I think he said Curcumin. Others will have to listen to verify that.
|
|
|
Post by Clement on Apr 16, 2020 10:20:13 GMT -5
When I look at the Pipeline my First Thought is you have NO approved drugs in your pipe...and why is that?? Because the Bar stops with all of them including Afrezza in column 1.... Also the Covid item should be moved up in Priority order in the Rows if we have our pipeline shut off for it..and also each item for Covid should be broken out with made up names even.. and detailing what upfront testing position it is in.. to show a rapid review of feasibility..special for Covid items only..for example one..already tested..doesn't work..red line it..show your on the other three..more pictorial..this one hides everything in an information icon..just saying.. When I look at it, the bar for Afrezza goes across all six columns, indicating approved status.
|
|
|
Post by golfeveryday on Apr 16, 2020 11:11:28 GMT -5
When I look at the Pipeline my First Thought is you have NO approved drugs in your pipe...and why is that?? Because the Bar stops with all of them including Afrezza in column 1.... Also the Covid item should be moved up in Priority order in the Rows if we have our pipeline shut off for it..and also each item for Covid should be broken out with made up names even.. and detailing what upfront testing position it is in.. to show a rapid review of feasibility..special for Covid items only..for example one..already tested..doesn't work..red line it..show your on the other three..more pictorial..this one hides everything in an information icon..just saying.. agree itell. They are way too mysterious about things and don’t know how to market anything well.
|
|
|
Post by nylefty on Apr 16, 2020 11:25:56 GMT -5
3/20
PROCESS FOR SECURITY HOLDER COMMUNICATIONS WITH THE BOARD OF DIRECTORS
Security holders of MannKind Corporation wishing to communicate with MannKind’s Board of Directors or an individual director may send a written communication to the Board or such director c/o MannKind Corporation, 30930 Russell Ranch Road, Suite 300, Westlake Village, California 91362, Attn: Corporate Secretary. Communications also may be sent by e-mail to the following address: board@mannkindcorp.com. Each communication must set forth the name and address of the MannKind stockholder on whose behalf the communication is sent. Each communication will be screened by MannKind’s Corporate Secretary to determine whether it is appropriate for presentation to the Board or such director. Examples of inappropriate communications include junk mail, mass mailings, product complaints, product inquiries, new product suggestions, resumes, job inquiries, surveys, business solicitations and advertisements, as well as unduly hostile, threatening, illegal, unsuitable, frivolous, patently offensive or otherwise inappropriate material. Communications determined by the Corporate Secretary to be appropriate for presentation to the Board or such director will be submitted to the Board or such director on a periodic basis. The process regarding security holder communications with the Board will be posted on MannKind’s website.
|
|
|
Post by lennymnkd on Apr 16, 2020 12:22:53 GMT -5
New product suggestions / I guess that leave me out ! ... moderna ‘s cold fusion .vaccine . to the Technosphere platform. OH WELL !
|
|
|
Post by rfogel on Apr 16, 2020 12:34:29 GMT -5
Has Mannkind had pre-IND meetings with the FDA for tadalafil, sumatriptan, or the cannabinoid formulations?
|
|
|
Post by itellthefuture777 on Apr 16, 2020 12:49:28 GMT -5
When I look at the Pipeline my First Thought is you have NO approved drugs in your pipe...and why is that?? Because the Bar stops with all of them including Afrezza in column 1.... Also the Covid item should be moved up in Priority order in the Rows if we have our pipeline shut off for it..and also each item for Covid should be broken out with made up names even.. and detailing what upfront testing position it is in.. to show a rapid review of feasibility..special for Covid items only..for example one..already tested..doesn't work..red line it..show your on the other three..more pictorial..this one hides everything in an information icon..just saying.. When I look at it, the bar for Afrezza goes across all six columns, indicating approved status. Sure I agree..if you're on a cell phone...but not if you use your laptop..
|
|
|
Post by Clement on Apr 16, 2020 12:57:28 GMT -5
When I look at it, the bar for Afrezza goes across all six columns, indicating approved status. Sure I agree..if you're on a cell phone...but not if you use your laptop.. I used my laptop.
|
|
|
Post by goyocafe on Apr 16, 2020 13:02:31 GMT -5
They indicate Afrezza Pediatric study is ready for Phase III. Did they read out the data for Phase II? I thought they still had one more age cohort to do?
|
|
|
Post by mango on Apr 16, 2020 13:44:37 GMT -5
They indicate Afrezza Pediatric study is ready for Phase III. Did they read out the data for Phase II? I thought they still had one more age cohort to do? In the info icon it has, "Currently finalizing with the FDA the study design for a Phase 3 clinical trial to evaluate the safety and efficacy of Afrezza in 8-17 year-old children and adolescents."
|
|